ScholarIQanswers from OpenAlex
Universitätsklinikum Knappschaftskrankenhaus Bochum
InstitutionResearch output, impact & collaborations
Universitätsklinikum Knappschaftskrankenhaus Bochum is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQrecord summary
Universitätsklinikum Knappschaftskrankenhaus Bochum is a research organisation in Bochum, DE. OpenAlex records 3,382 works and 165,124 citations for it. 930 researchers list it as their most recent affiliation.
How many works does Universitätsklinikum Knappschaftskrankenhaus Bochum have?
ScholarIQindexed works
Universitätsklinikum Knappschaftskrankenhaus Bochum has 3,382 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universitätsklinikum Knappschaftskrankenhaus Bochum have?
ScholarIQcitation count
Universitätsklinikum Knappschaftskrankenhaus Bochum has 165,124 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQresearcher count
Universitätsklinikum Knappschaftskrankenhaus Bochum has 930 researchers in the ScholarIQ index.
What is the average h-index at Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQavg h-index
Universitätsklinikum Knappschaftskrankenhaus Bochum has an average h-index of 78 in OpenAlex.
What is the ROR of Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQror
The ROR for Universitätsklinikum Knappschaftskrankenhaus Bochum is on the source record.
What is the OpenAlex record for Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQopenalex
The OpenAlex for Universitätsklinikum Knappschaftskrankenhaus Bochum is on the source record.
Who are the most-cited researchers behind Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQtop researchers by citations
What are the most-cited papers on Universitätsklinikum Knappschaftskrankenhaus Bochum?
ScholarIQmost cited works
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Claudia Pauligk, Hans‐Georg Kopp, Georg Martin Haag, Kim Barbara Luley, Johannes Meiler, Nils Homann, Sylvie Lorenzen, Harald Schmalenberg, Stephan Probst, Michael Koenigsmann, Matthias Egger, Nicole Prasnikar, Karel Caca, Jörg Trojan, Uwe M. Martens, Andreas Block, Wolfgang Fischbach, Rolf Mahlberg, Michael Clemens, Gerald Illerhaus, Katja Zirlik, Dirk Behringer, Wolff Schmiegel, Michael Pohl, Michael Heike, Ulrich Ronellenfitsch, Martin Schüler, Wolf O. Bechstein, Alfred Königsrainer, Timo Gaiser, Peter Schirmacher, Wael Hozaeel, Alexander Reichart, Thorsten Oliver Goetze, Mark Sievert, Elke Jäger, Stefan Mönig, Andrea Tannapfel
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Mev Dominguez–Valentin, Julian R. Sampson, Toni T. Seppälä, Sanne W. ten Broeke, John‐Paul Plazzer, Sigve Nakken, Christoph Engel, Stefan Aretz, Mark A. Jenkins, Lone Sunde, Inge Bernstein, Gabriel Capellá, Francesc Balaguer, Huw Thomas, D. Gareth Evans, John Burn, Marc S. Greenblatt, Eivind Hovig, Wouter H. de Vos tot Nederveen Cappel, Rolf H. Sijmons, Lucio Bertario, Maria Grazia Tibiletti, Giulia Martina Cavestro, Annika Lindblom, Adriana Della Valle, Francisco López‐Köstner, Nathan Gluck, Lior H. Katz, Karl Heinimann, Carlos Vaccaro, Reinhard Büttner, Heike Görgens, Elke Holinski‐Feder, Monika Morak, Stefanie Holzapfel, Robert Hüneburg, Magnus von Knebel Doeberitz, Markus Loeffler, Nils Rahner, Hans K. Schackert, Verena Steinke‐Lange, Wolff Schmiegel, Deepak Vangala, Kirsi Pylvänäinen, Laura Renkonen‐Sinisalo, John L. Hopper, Aung Ko Win, Robert W. Haile, Noralane M. Lindor, Steven Gallinger, Loı̈c Le Marchand, Polly A. Newcomb, Jane C. Figueiredo, Stephen N. Thibodeau, Karin Wadt, Christina Therkildsen, Henrik Okkels, Zohreh Ketabi, Leticia Moreira, Ariadna Sánchez, Miquel Serra‐Burriel, Marta Pineda, Matilde Navarro, Ignacio Blanco, Kate Green, Fiona Lalloo, Emma J. Crosbie, James Hill, Oliver G. Denton, Ian M. Frayling, Einar Andreas Rødland, Hans F. A. Vasen, Miriam Mints, Florencia Neffa, Patricia Esperón, Karin Álvarez, Revital Kariv, Guy Rosner, Tamara Alejandra Piñero, María Laura González, Pablo Kalfayan, Douglas Tjandra, Ingrid Winship, Finlay Macrae, Gabriela Möslein, Jukka‐Pekka Mecklin, Maartje Nielsen, Pål Møller
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas, Michael Allgäuer, Bülent Polat, Günther Klautke, Gerhard G. Grabenbauer, Rainer Fietkau, Thomas Kuhnt, Ludger Staib, Thomas Brunner, Anca‐Ligia Grosu, Wolff Schmiegel, Lutz Jacobasch, Jürgen Weitz, Gunnar Folprecht, Anke Schlenska‐Lange, Michael Flentje, Christoph‐Thomas Germer, Robert Grützmann, Matthias Schwarzbach, Vittorio Paolucci, Wolf O. Bechstein, Tim Friede, Michael Ghadimi, Ralf‐Dieter Hofheinz, Claus Rödel, on behalf of the German Rectal Cancer Study Group
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat, Günther Klautke, Gerhard G. Grabenbauer, Rainer Fietkau, Thomas Kuhnt, Ludger Staib, Thomas Brunner, Anca‐Ligia Grosu, Simon Kirste, Lutz Jacobasch, Michael Allgäuer, Michael Flentje, Christoph‐Thomas Germer, Robert Grützmann, Guido Hildebrandt, Matthias Schwarzbach, Wolf O. Bechstein, Heiko Sülberg, Tim Friede, Jochen Gaedcke, Michael Ghadimi, Ralf‐Dieter Hofheinz, Claus Rödel, German Rectal Cancer Study Group, Detlef Imhoff, Guido Woeste, Nils Habbe, Ursula Pession, Martin‐Leo Hansmann, Peter J. Wild, Stephan Falk, Petra Hödl, A Serebrennikov, Sanja Schmeck, Vittorio Paolucci, Stephan Sahm, Martin Eichel, Giovanna Römer, W. Bank, Nicolas Moosmann, Jan Braess, P. Piso, Heinrich Wiesinger, Peter Kappl, Elisabeth Germer, Monika Warmuth‐Metz, Volker Kunzmann, Katica Krajinovic, Andreas Rosenwald, Thorsten Alexander Bley, Ulrich Stölzel, Manfred Dörne, L. Renziehausen, Joachim Boese-Land, Dietrich Meißner, D. Burchert, Olaf Dirsch, Jörg Olaf Habeck, Klaus Kirchhof, Christof Lamberti, B. J. Leibl, Andreas Gschwendtner, Godehard Lahmer, Marga Lang-Welzenbach, Werner Hohenberger, Thomas Kuhnt, Kirsten Papsdorf, Christian Wittekind, Christine Volkheimer, Frederik Wenz, Kirsten Merx, Stefan Post, Timo Gaiser, Ulrike Attenberger, Michael Geißler, Jörn Sträter, Helmut Gnann, Stefan Krämer, Michael Henke, Henning Schäfer, Philipp Manegold, Hannes Neeff, Peter Bronsert, Wolff Schmiegel, Michael Pohl, Christian Möllecken, Irenäus A. Adamietz, Richard Viehbahn, Andrea Tannapfel, Jens Freiberg‐Richter, Thorsten Jacobi, Wolfgang Wendt, Klaus Holzweißig, Thomas Kittner, Ullrich Graeven, Christiane Lange, U. Kania, Elisabeth Rösler
How much of the research on Universitätsklinikum Knappschaftskrankenhaus Bochum is open access?
ScholarIQopen access share
75%OPEN ACCESS